Opportunity Information: Apply for CDC RFA GH12 1234
Apply for CDC RFA GH12 1234
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthening of the National External Quality Assessment (EQA) Program through Establishment and Implementation of an Efficient Distribution and Analysis of Proficiency Materials for Human Immunodeficiency Virus (HIV), Tuberculosis, and Opportunisti" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Feb 1, 2012 and posted on Feb 1, 2012.
- Applicants must submit their applications by Apr 2, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,150,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants that can apply for this funding opportunity are listed below Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) For profit organizations (other than small business) Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) Non domestic (non U.S.) entity Other (specify) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC cooperative agreement (Funding Opportunity Number CDC RFA GH12 1234) supports work to strengthen a national External Quality Assessment (EQA) program by improving how proficiency testing materials are distributed and how results are collected, analyzed, and used for quality improvement. The focus is on laboratory quality systems tied to HIV, tuberculosis, and related opportunistic infections, aligning with the broader goals of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). In practical terms, the opportunity is aimed at helping countries build or enhance reliable EQA operations so testing sites can routinely verify their performance, identify gaps, and take corrective actions that improve the accuracy and consistency of diagnostic and monitoring services.
The program is administered by the Centers for Disease Control and Prevention (CDC) within the U.S. Department of Health and Human Services, under the leadership of the U.S. Global AIDS Coordinator. CDC describes its approach as working with host countries and other partners to assess country needs and then design tailored assistance that fits the host nation's strategic plan and partnership framework. That framing signals that funded activities are expected to be coordinated with national laboratory and disease control priorities rather than run as stand-alone projects, and that the awardee will likely work closely with in-country stakeholders responsible for laboratory networks, specimen referral systems, and quality management.
The funding instrument is a cooperative agreement, which typically means CDC anticipates substantial involvement during implementation (for example, technical input, collaboration on work planning, or shared oversight of deliverables). The activity category is Health, and the CFDA number listed is 93.067 (Global AIDS). CDC expected to make two awards under this announcement. The estimated total funding is $1,150,000, with an award ceiling of $250,000 per award. No cost sharing or matching is required, which lowers the barrier for organizations that may not have non-federal funds available to contribute.
While the full technical scope would be detailed in the complete announcement, the title and description make clear that the core deliverable is a more efficient, better-functioning national EQA system specifically around proficiency testing: getting proficiency materials to participating sites in a reliable, timely way and ensuring results are managed in a way that supports meaningful analysis and feedback. That implies operational improvements such as strengthening distribution logistics, improving data flow and reporting timelines, standardizing methods for scoring and interpretation, and ensuring results lead to corrective and preventive actions at laboratories. Because EQA is often a networked activity involving many testing sites, national reference laboratories, and sometimes multiple disease programs, the work also commonly includes coordination, training, and system design so that EQA supports routine service delivery at scale.
Eligibility is broad and includes U.S. and non-U.S. entities across the nonprofit, for-profit, academic, clinical, community-based, and government sectors. Specifically listed are nonprofits with and without 501(c)(3) status, for-profit organizations (including small, minority-, and women-owned businesses), universities and colleges, research institutions, hospitals, community-based and faith-based organizations, tribal governments and tribal organizations, Alaska Native and Urban Indian health organizations, tribal epidemiology centers, and state/local governments and their bona fide agents, as well as non-domestic (non-U.S.) entities. Applicants applying as a bona fide agent for a state or local government must include a legal, binding agreement documenting that status when submitting the application through Grants.gov.
Key dates show the announcement was posted and created on February 1, 2012, with an original and current closing date of April 2, 2012, and an archive date of May 2, 2012. For assistance accessing the full announcement, CDC provided contact information for PGOTIMS (phone 770-488-2700; email pgotim@cdc.gov).
Frequently Asked Questions (FAQs)
What is the name and number of this funding opportunity?
This opportunity is a CDC cooperative agreement: Funding Opportunity Number CDC RFA GH12 1234.
Which federal agency is offering and administering the award?
The program is administered by the Centers for Disease Control and Prevention (CDC) within the U.S. Department of Health and Human Services.
What type of funding instrument is this?
The funding instrument is a cooperative agreement. This generally indicates CDC expects substantial involvement during implementation, such as technical input, collaboration on work planning, or shared oversight of deliverables.
What is the main purpose of the cooperative agreement?
The purpose is to strengthen a national External Quality Assessment (EQA) program by improving how proficiency testing materials are distributed and how results are collected, analyzed, and used for quality improvement.
What does the opportunity focus on within laboratory systems?
The focus is on laboratory quality systems tied to HIV, tuberculosis, and related opportunistic infections, aligning with the broader goals of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR).
What practical outcomes is CDC aiming for through this award?
The opportunity is aimed at helping countries build or enhance reliable EQA operations so testing sites can routinely verify their performance, identify gaps, and take corrective actions that improve the accuracy and consistency of diagnostic and monitoring services.
What are the core activities implied by the description?
Based on the title and summary, the core deliverable is a more efficient, better-functioning national EQA system around proficiency testing. This implies improvements such as more reliable and timely distribution logistics for proficiency testing materials and stronger systems to manage results so they support meaningful analysis and feedback for quality improvement.
What kinds of system improvements may be included in the work?
The description suggests operational improvements such as strengthening distribution logistics, improving data flow and reporting timelines, standardizing methods for scoring and interpretation, and ensuring results lead to corrective and preventive actions at laboratories.
Does CDC expect this work to be coordinated with country priorities?
Yes. CDC describes an approach of working with host countries and other partners to assess country needs and design tailored assistance that fits the host nation's strategic plan and partnership framework. This signals funded activities are expected to be coordinated with national laboratory and disease control priorities rather than run as stand-alone projects.
Who is expected to be involved at the country level?
The summary indicates the awardee will likely work closely with in-country stakeholders responsible for laboratory networks, specimen referral systems, and quality management, since EQA is typically a networked national activity.
What is the activity category for this opportunity?
The activity category is Health.
What CFDA number is associated with this program?
The CFDA number listed is 93.067 (Global AIDS).
How many awards did CDC expect to make?
CDC expected to make two awards under this announcement.
What is the estimated total funding amount?
The estimated total funding is $1,150,000.
What is the maximum amount (ceiling) per award?
The award ceiling is $250,000 per award.
Is cost sharing or matching required?
No cost sharing or matching is required.
Who is eligible to apply?
Eligibility is broad and includes U.S. and non-U.S. entities across nonprofit, for-profit, academic, clinical, community-based, and government sectors.
Which nonprofit organizations are eligible?
Nonprofits with and without 501(c)(3) status are eligible to apply.
Are for-profit organizations eligible to apply?
Yes. For-profit organizations are eligible, including small businesses and minority- and women-owned businesses.
Are universities, colleges, hospitals, and research institutions eligible?
Yes. Universities and colleges, research institutions, and hospitals are specifically listed as eligible entity types.
Are community-based and faith-based organizations eligible?
Yes. Community-based and faith-based organizations are specifically listed as eligible.
Are government entities eligible?
Yes. Eligibility includes state and local governments and their bona fide agents, as well as tribal governments and tribal organizations.
Are tribal and Native health organizations eligible?
Yes. The eligibility list includes tribal governments and tribal organizations, Alaska Native and Urban Indian health organizations, and tribal epidemiology centers.
Are non-U.S. (non-domestic) entities eligible?
Yes. Non-domestic (non-U.S.) entities are explicitly listed as eligible to apply.
If applying as a bona fide agent for a state or local government, is special documentation required?
Yes. Applicants applying as a bona fide agent for a state or local government must include a legal, binding agreement documenting that status when submitting the application through Grants.gov.
When was this opportunity posted and created?
The announcement was posted and created on February 1, 2012.
What was the application closing date?
The original and current closing date was April 2, 2012.
When was the opportunity archived?
The archive date was May 2, 2012.
Where can applicants get help accessing the full announcement?
CDC provided contact information for PGOTIMS for assistance accessing the full announcement: phone 770-488-2700; email pgotim@cdc.gov.
What does "substantial CDC involvement" typically mean in a cooperative agreement?
In this context, it means CDC anticipates being actively involved during implementation, for example through technical input, collaboration on work planning, or shared oversight of deliverables.
How does this opportunity relate to PEPFAR?
The laboratory quality systems focus (HIV, tuberculosis, and related opportunistic infections) is described as aligning with the broader goals of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), under the leadership of the U.S. Global AIDS Coordinator.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Connecticut Conservation Innovation Grant FY 2012 Announcement for Program Funding
Previous opportunity: BJA FY 12 Enhanced Collaborative Model to Combat Human Trafficking
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH12 1234
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH12 1234) also looked into and applied for these:
| Funding Opportunity |
|---|
| Partnerships for Development of Vaccine Technologies (R01) Apply for RFA AI 12 014 Funding Number: RFA AI 12 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource Access for the Bridging Interventional Development Gaps Program (X01) Apply for PAR 12 092 Funding Number: PAR 12 092 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NU HITES Apply for RFA 617 12 000005 Funding Number: RFA 617 12 000005 Agency: Uganda USAID Kampala Category: Health Funding Amount: $50,000,000 |
| Strengthening Systems, Capacity, and Data Collection with a Focus on Strategic Information in South Sudan under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1256 Funding Number: CDC RFA GH12 1256 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Engaging Local Indigenous Organizations in Improving Quality and Efficiency of HIV Care and Treatment Services in Ukraine under the Presidents Emergency Plan for HIV/AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1227 Funding Number: CDC RFA GH12 1227 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $700,000 |
| Establishment of an expanded Caribbean HIV/AIDS monitoring and evaluation technical assistance unit within the Caribbean Health Research Council (CHRC) under the Presidents Emergency Plan for AIDS Relief (PEPFAR Apply for CDC RFA GH12 1205 Funding Number: CDC RFA GH12 1205 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Planning Grant The Money Follows the Person Rebalancing Demonstration Program Apply for CMS 1LI 12 001 Funding Number: CMS 1LI 12 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $200,000 |
| Expanding Participation of People with Disabilities in USAID Activities andStrengthen the Capacities of Disabled Peoples Organizations (DPOs) Apply for RFA 114 12 000002 Funding Number: RFA 114 12 000002 Agency: Georgia USAID Tbilisi Category: Health Funding Amount: $600,000 |
| Implementation of a Program to Build the Institutional Apply for CDC RFA GH12 1243 Funding Number: CDC RFA GH12 1243 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,130,000 |
| Modeling Social Behavior (R01) Apply for RFA GM 13 006 Funding Number: RFA GM 13 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Grand Challenges in Global Mental Health Integrating Mental Health into Chronic Disease Care Provision in Low and Middle Income Countries (R01) Apply for RFA MH 13 040 Funding Number: RFA MH 13 040 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Increasing Human Resources for Health and Epidemiological Capacity in the Republic of Guyana through a University Training Program under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1208 Funding Number: CDC RFA GH12 1208 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $440,000 |
| Sober Truth on Preventing Underage Drinking Act Grants Apply for SP 12 003 Funding Number: SP 12 003 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $50,000 |
| Improving Quality of Care and Health Impact through Sustainable, Integrated, Innovative Information System Technologies in Malawi under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1250 Funding Number: CDC RFA GH12 1250 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $8,000,000 |
| Ancillary Studies in PREDICT HD (U01) Apply for PAR 12 097 Funding Number: PAR 12 097 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ancillary Domain Validation Patient Reported Outcomes Measurement Information System (PROMIS) Studies (R01) Apply for RFA AR 12 007 Funding Number: RFA AR 12 007 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| National Forum for State and Territorial Chief Executives Apply for HRSA 12 152 Funding Number: HRSA 12 152 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Reduce the Incidence and Mitigate the Impact of HIV/AIDS in Mali under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1231 Funding Number: CDC RFA GH12 1231 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Technical Assistance to The Ministry of Health (MOH) for HIV Services and Program Transition in Zambezia Province of the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1224 Funding Number: CDC RFA GH12 1224 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $25,000,000 |
| Stem Cell Approaches to Developing New Therapies for Ocular Diseases (R01) Apply for RFA EY 12 001 Funding Number: RFA EY 12 001 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH12 1234", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.